Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$13.85 – $29.15
20% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $929.72B | $981.79B | $962.52B | $1.04T | $1.28T | $1.60T | $1.89T | $2.14T |
| Cost of revenue | $364.61B | $343.21B | $338.29B | $362.80B | $363.52B | $415.32B | $415.80B | $673.26B |
| Gross profit | $565.11B | $638.59B | $624.23B | $682.09B | $914.95B | $1.19T | $1.47T | $1.46T |
| Gross margin | 60.8% | 65.0% | 64.9% | 65.3% | 71.6% | 74.1% | 78.0% | 68.5% |
| R&D | $203.71B | $197.47B | $227.35B | $260.23B | $341.57B | $365.17B | $435.96B | $468.94B |
| Operating income | $90.46B | $118.03B | $63.80B | $73.03B | $120.58B | $211.59B | $331.93B | $208.62B |
| EBITDA | $137.91B | $170.64B | $134.26B | $131.27B | $169.72B | $271.24B | $436.13B | $286.56B |
| Net income | $93.41B | $129.07B | $75.96B | $66.97B | $109.19B | $200.73B | $295.76B | $261.51B |
| Net margin | 10.0% | 13.1% | 7.9% | 6.4% | 8.5% | 12.5% | 15.7% | 12.2% |
| EPS (diluted) | 47.96 | 66.27 | 39.11 | 34.91 | 56.91 | 104.62 | 155.87 | 140.61 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $2.33T | $163.93 | $155.48–$185.54 | 3 |
| 2028 | $2.40T | $202.45 | $192.01–$229.14 | 4 |
| 2029 | $2.65T | $192.16 | $182.25–$217.50 | 3 |
| 2030 | $3.07T | $255.73 | $242.55–$289.45 | 3 |
Forward consensus · source: Financial Modeling Prep
DAIICHI SANKYO CO LTD ORD
No one on the platform currently holds DSKYF.
No tracked institution reports a position in DSKYF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $50.0000 | |
| 2026-09-30 | $50.0000 | |
| 2026-03-31 | $39.0000 | 2026-06-23 |
| 2025-09-30 | $39.0000 | 2025-12-10 |
| 2025-03-31 | $30.0000 | 2025-06-24 |
| 2024-09-30 | $30.0000 | 2024-12-10 |
| 2024-03-28 | $30.0000 | 2024-06-18 |
| 2023-09-29 | $20.0000 | 2023-12-08 |
| Execution date | Ratio |
|---|---|
| 2020-09-29 | 3-for-1 |
No one on the platform has traded DSKYF yet.
| $61.5B |
| — |
| OTSKYOtsuka Holdings Co., Ltd. | $33.48 | -1.70% | $35.3B | — |
| TKPHFTakeda Pharmaceutical Company Limited | $30.06 | -1.70% | $47.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× earnings vs its 0.4× historical median P/E.
Fair value ≈ $66.65 · price $16.94 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.